Next Technology (NXTT) Competitors

OptimizeRx (NASDAQ:OPRX) and Next Technology (NASDAQ:NXTT) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment, earnings and community ranking.

Do insiders & institutionals have more ownership in OPRX or NXTT?

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 2.7% of Next Technology shares are owned by institutional investors. 6.1% of OptimizeRx shares are owned by company insiders. Comparatively, 37.5% of Next Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Do analysts prefer OPRX or NXTT?

OptimizeRx presently has a consensus target price of $10.42, indicating a potential upside of 135.67%. Given OptimizeRx's stronger consensus rating and higher probable upside, equities analysts clearly believe OptimizeRx is more favorable than Next Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86
Next Technology	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is OPRX or NXTT more profitable?

Next Technology has a net margin of 0.00% compared to OptimizeRx's net margin of -27.41%. Next Technology's return on equity of 54.87% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	-27.41%	-4.92%	-3.41%
Next Technology	N/A	54.87%	50.18%

Which has more risk & volatility, OPRX or NXTT?

OptimizeRx has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, Next Technology has a beta of 2.17, meaning that its stock price is 117% more volatile than the S&P 500.

Does the MarketBeat Community believe in OPRX or NXTT?

OptimizeRx received 152 more outperform votes than Next Technology when rated by MarketBeat users.

Company	Underperform	Outperform
OptimizeRx	Outperform Votes 152 63.87%	Underperform Votes 86 36.13%
Next Technology	N/A	N/A

Does the media refer more to OPRX or NXTT?

In the previous week, OptimizeRx had 17 more articles in the media than Next Technology. MarketBeat recorded 18 mentions for OptimizeRx and 1 mentions for Next Technology. OptimizeRx's average media sentiment score of 0.19 beat Next Technology's score of -0.15 indicating that OptimizeRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	1 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Next Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has better earnings & valuation, OPRX or NXTT?

Next Technology has lower revenue, but higher earnings than OptimizeRx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$71.52M	1.14	-$17.57M	-$1.33	-3.32
Next Technology	$2.63M	5.31	-$9.92M	N/A	N/A

Summary

OptimizeRx beats Next Technology on 8 of the 15 factors compared between the two stocks.